InvestorsHub Logo
Followers 50
Posts 11527
Boards Moderated 0
Alias Born 06/15/2014

Re: Whalatane post# 382243

Monday, 07/04/2022 4:31:05 PM

Monday, July 04, 2022 4:31:05 PM

Post# of 427978
Kiwi, I think you know that there are not many trials using MO daily for over 2 years. But anyway you are deviating from my point of you calling 4gm MO a high dose.

Some have also argued that the mineral oil-containing placebo may have raised on-treatment LDL-C levels and increased both atherogenic lipoproteins and C-reactive protein which, in turn, potentially magnified the observed treatment difference between the icosapent ethyl and placebo groups.47 However, even if true, the 5?mg/dL difference in LDL-C in the placebo arm relative to the EPA arm would likely explain at most 3% of the relative risk reduction, which still leaves unexplained a large observed 20–25% risk reduction with EPA. Of note, the authors are presently unaware of any data proving that mineral oil in the minute quantities used in this trial (~2?mL twice daily) would cause cardiovascular harm.



https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308541/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News